RedHill Biopharma (RDHL) Depreciation & Amortization (CF) (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Depreciation & Amortization (CF) of $491000.0 for Q4 2022, up 9.35% year-over-year from $449000.0 in Q4 2021, and little changed quarter-over-quarter from $491000.0 in Q3 2022.
RedHill Biopharma (RDHL) Depreciation & Amortization (CF) (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Depreciation & Amortization (CF) for 11 consecutive years, with $491000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Depreciation & Amortization (CF) rose 9.35% year-over-year to $491000.0; the TTM figure through Dec 2023 stood at $491000.0 (down 77.01% YoY), while the FY2025 annual figure was $384000.0, down 34.69% from the prior year.
- Depreciation & Amortization (CF) steadied at $491000.0 in Q4 2022 per RDHL's latest filing, from $491000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $617000.0 in Q2 2022 and bottomed at $22000.0 in Q1 2018.
- Historically, Depreciation & Amortization (CF) has averaged $342350.0 across 5 years, with a median of $433000.0 in 2020.
- Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) dropped 15.38% — and 2019, when it jumped 1209.09%.
- RedHill Biopharma's Depreciation & Amortization (CF) stood at $23000.0 in 2018, then jumped by 1000.0% to $253000.0 in 2019, then soared by 86.96% to $473000.0 in 2020, then dropped by 5.07% to $449000.0 in 2021, then grew by 9.35% to $491000.0 in 2022.
- Business Quant data shows RDHL's Depreciation & Amortization (CF) at $491000.0 in Q4 2022, $491000.0 in Q3 2022, and $617000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 491,000.00 |
| Dec 31, 2022 | 491,000.00 |
| Sep 30, 2022 | 491,000.00 |
| Sep 30, 2022 | 491,000.00 |
| Jun 30, 2022 | 617,000.00 |
| Jun 30, 2022 | 617,000.00 |
| Mar 31, 2022 | 537,000.00 |
| Mar 31, 2022 | 537,000.00 |
| Dec 31, 2021 | 449,000.00 |
| Dec 31, 2021 | 449,000.00 |
| Sep 30, 2021 | 507,000.00 |
| Sep 30, 2021 | 507,000.00 |
| Jun 30, 2021 | 465,000.00 |
| Jun 30, 2021 | 465,000.00 |
| Mar 31, 2021 | 492,000.00 |
| Mar 31, 2021 | 492,000.00 |
| Dec 31, 2020 | 473,000.00 |
| Dec 31, 2020 | 473,000.00 |
| Sep 30, 2020 | 470,000.00 |
| Sep 30, 2020 | 470,000.00 |